Pain Relief Roll-on
Product Images NDC 50804-774

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pain Relief Roll-on (NDC 50804-774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Good Sense, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Back)

Image Description (Back)
This is a topical anesthetic designed to provide temporary relief of pain and itching. It should only be used as directed and caution should be taken to avoid contact with the eyes. It is not recommended for use on raw or blistered areas, and if the condition worsens, medical attention should be sought. Children should be kept away from the product and if swallowed, medical help should be sought right away. Directions indicate that it can be applied up to three to four times daily for adults and children over two years old, but younger children should consult a doctor. The product includes various ingredients such as Dimethicone, Isodium EDTA and Methyiparaben. The product is not manufactured or distributed by Chattem, Inc. the distributor of Aspercreme.*
FDA Label Image

Image Description (Front)

Image Description (Front)
This appears to be a product advertisement for a roll-on gel with 4% lidocaine HCI, marketed as a pain relief solution. It promises temporary relief of pain without irritation and is easy to apply to specific areas with a roll-on applicator. It is fragrance-free and has "maximum strength."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.